ACT, CIRM and the Test of Time
Christopher Thomas Scott, executive director of the Stem Cells in Society program at Stanford University, has offered the following commentary. Scott is also the author of "Stem Cell Now."
Will ACT save embryonic stem cell research? No way.
Advanced Cell Technology's announcement in Nature last week wound up the rhetoric—yet again—surrounding embryonic s…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.